FIRSTSense Medical, LLC
A revolutionary breast cancer tester with 95% projected detection rate. It will be painless, radiation free, take 7 minutes and be done in the doctor’s office.
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Pontiac, MI, US
- Currency USD
- Founded 2008
- Employees 9
- Website firstsensemed.com
Company Summary
The product is a proprietary, low cost, non-invasive, radiation-free breast cancer screen that uses a military grade thermal camera to measure heat/vascular patterns which are indicative of breast cancer. The test is takes about about 8 minutes .
The FirstSense Medical detection rate goal is 95% (i.e. 5% false negatives) with a specificity rate of 91% (i.e. 9% false positives). These are the best early detection rates in the world.
Team
-
COO
Versatile and strategically oriented general management executive with more than 25 years of success in wide variety of manufacturing, service, consulting, and distribution industry settings maximizing profitability and delivering many billions of dollars of organic and acquisition-fueled growth. Founded and built global business and legal consulting firm to $10 million/year with global client base ranging from start-ups to large companies.
-
Paul AngottPresident
President and founder, is an entrepreneur with broad business experience in management, technical innovation and sales and marketing, including building national sales organizations. He has established five companies, has 40 patents and has developed products for wireless and laser technology, residential security and home products. Paul was named 2011 Entrepreneur of the Year by Automation Alley.
-
KaC Cheok, PhDVice President of Engineering
Vice President of Engineering, is responsible for developing software code to analyze thermal imaging results and assisting in advanced imaging techniques such as neural networks. Dr. Cheok is active in the research areas of computer controlled systems involving artificial intelligence and computer visualization, and he previously wrote the control strategy for the M1 Tank and the Segway.
-
Interim CFO
Karen is responsible for financial reporting and analysis, control functions, forecasting cash flow, cost management, and business plan development. She has over 25 years’ experience in accounting, finance, and operations, working in a variety of industries, with the last 12 years in CFO and financial management roles with entrepreneurial ventures.
Advisors
-
Brad OleshanskyBoard Member - is a corporate attorney with extensive entrepreneurial experience. He is the former CEO of BIG Communications, a leading healthcare communications company serving the biopharma and device industries.UnconfirmedTom VaughnLawyer, Dykema Gossett PLLCUnconfirmedRoger Newton, PhDBoard Member - investor, is the co-developer of Lipitor and was founder, President and CEO of Esperion. Newton sold Esperion to Pfizer for $1.3 billion. It has been restarted as an independent company, led by Newton.Unconfirmed
-
Greg Auner, PhDBoard Member - is Professor of Biomedical Engineering at Wayne State University and Dir. of Smart Sensors and Integrated Microsystems program, which researches leading-edge products including projects for NASA, Karmanos Cancer Center & Susan G. Komen.UnconfirmedJeff Forman, MDBoard Member - is National Director of Clinical Research at 21st Century Oncology, President of the Fund for Cancer Research and Professor of Radiation Oncology at Wayne State University.UnconfirmedNilesh Patel, PhDPattern Recognition ConsultantUnconfirmed
-
Richard Beltramini, PhDMarket ResearchUnconfirmedThermal Imaging
Previous Investors
-
Board MemberBrad OleshanskyBoard MemberUnconfirmedPrivate ListUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.